Experimental drug works best for Alzheimer’s patients treated as early as possible
By Deena Beasley (Reuters) -An experimental drug from Eli Lilly works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, researchers said on Monday, in the latest promising development for treating the most common form of dementia. The drug, donanemab, has been shown to slow…
